This results in increased production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF) and Human Macrophage Inflammatory Protein 2 (MIP-2), enhancing the anti-tumor effects of recombinant oncolytic Adv (83). Here, TNF is linked to neoplasm.